Cargando…
Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity
It is unclear the extent to which best practices for phenotyping disease states from electronic medical records (EMRs) translate to phenotyping adverse drug events. Here we use statin-induced myotoxicity as a case study to identify best practices in this area. We compared multiple phenotyping algori...
Autores principales: | Wiley, Laura K., Moretz, Jeremy D., Denny, Joshua C., Peterson, Josh F., Bush, William S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525276/ https://www.ncbi.nlm.nih.gov/pubmed/26306287 |
Ejemplares similares
-
Phenotype Standardization for Statin-Induced Myotoxicity
por: Alfirevic, A, et al.
Publicado: (2014) -
Pharmacogenetics of Statin-Induced Myotoxicity
por: Kee, Ping Siu, et al.
Publicado: (2020) -
The role of acid-base imbalance in statin-induced myotoxicity
por: Taha, Dhiaa A., et al.
Publicado: (2016) -
A serious adverse drug reaction probably induced by clonazepam: a case report of myotoxicity
por: Han, Xiaonian, et al.
Publicado: (2019) -
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019)